Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting

BACKGROUND: The combination chemotherapy regimens of nab-paclitaxel plus gemcitabine (nab-p + G) and FOLFIRINOX (FFX) have each demonstrated improved survival compared with gemcitabine monotherapy in clinical trials for metastatic pancreatic cancer; however, limited comparative data exist. OBJECTIVE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drugs Real World Outcomes
Main Authors: Cartwright, Thomas H., Parisi, Monika, Espirito, Janet L., Wilson, Thomas W., Pelletier, Corey, Patel, Manish, Babiker, Hani M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2018
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6119168/
https://ncbi.nlm.nih.gov/pubmed/29946913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-018-0137-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados